Targeted expression of IGF-1 in the central nervous system fails to protect mice from experimental autoimmune encephalomyelitis.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of Neuroimmunology

• Publication date

  2005-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.JNEUROIM.2005.06.033PMID 16120466
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Experimental autoimmune encephalomyelitis repressed by microglial paralysis

  2005cited by this paper
• IGF-I instructs multipotent adult neural progenitor cells to become oligodendrocytes

  2004cited by this paper
• Retrograde Viral Delivery of IGF-1 Prolongs Survival in a Mouse ALS Model

  2003cited by this paper
• Insulin-Like Growth Factor (IGF) Signaling through Type 1 IGF Receptor Plays an Important Role in Remyelination

  2003cited by this paper
• Protection Against Experimental Autoimmune Encephalomyelitis Generated by a Recombinant Adenovirus Vector Expressing the Vβ8.2 TCR Is Disrupted by Coadministration with Vectors Expressing Either IL-4 or -101

  2003cited by this paper
• A pilot study of recombinant insulin-like growth factor-1 in seven multiple sclerosis patients

  2002cited by this paper
• IGF‐I and microglia/macrophage proliferation in the ischemic mouse brain

  2002cited by this paper
• Increasing local levels of IGF-I mRNA expression using adenoviral vectors does not alter oligodendrocyte remyelination in the CNS of aged rats.

  2002cited by this paper
• Activation of Natural Killer T Cells Potentiates or Prevents Experimental Autoimmune Encephalomyelitis

  2001cited by this paper
• Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions.

  2000cited by this paper
• Insulin-like growth factor-1 fails to enhance central nervous system myelin repair during autoimmune demyelination.

  2000cited by this paper
• Mature oligodendrocyte apoptosis precedes IGF‐1 production and oligodendrocyte progenitor accumulation and differentiation during demyelination/remyelination

  2000cited by this paper
• Distinctive patterns of PDGF-A, FGF-2, IGF-I, and TGF-beta1 gene expression during remyelination of experimentally-induced spinal cord demyelination.

  1999cited by this paper
• Autoimmunity to Myelin Oligodendrocyte Glycoprotein in Rats Mimics the Spectrum of Multiple Sclerosis Pathology

  1998cited by this paper
• The role of growth hormone and insulin-like growth factors in the immune system

  1998cited by this paper
• Chronic Relapsing Experimental Autoimmune Encephalomyelitis: Effects of Insulin‐like Growth Factor‐I Treatment on Clinical Deficits, Lesion Severity, Glial Responses, and Blood Brain Barrier Defects

  1998cited by this paper
• Regulation of experimental autoimmune encephalomyelitis with insulin-like growth factor (IGF-1) and IGF-1/IGF-binding protein-3 complex (IGF-1/IGFBP3).

  1998cited by this paper
• Production of High-Titer Recombinant Adeno-Associated Virus Vectors in the Absence of Helper Adenovirus

  1998cited by this paper
• Insulin‐like growth factor‐I treatment reduces immune cell responses in acute non‐demyelinative experimental autoimmune encephalomyelitis

  1997cited by this paper
• Major histocompatibility complex binding affinity of an antigenic determinant is crucial for the differential secretion of interleukin 4/5 or interferon gamma by T cells.

  1995cited by this paper
• Igf1 gene disruption results in reduced brain size, CNS hypomyelination, and loss of hippocampal granule and striatal parvalbumin-containing neurons.

  1995cited by this paper
• Developing oligodendroglia express mRNA for insulin‐like growth factor‐I, a regulator of oligodendrocyte development

  1995cited by this paper
• Insulin-like growth factor I treatment reduces clinical deficits and lesion severity in acute demyelinating experimental autoimmune encephalomyelitis

  1995cited by this paper
• Myelin oligodendrocyte glycoprotein induces a demyelinating encephalomyelitis resembling multiple sclerosis.

  1995cited by this paper
• Insulin-like growth factor I treatment reduces demyelination and up-regulates gene expression of myelin-related proteins in experimental autoimmune encephalomyelitis.

  1995cited by this paper
• Astrocytes express insulin-like growth factor-I (IGF-I) and its binding protein, IGFBP-2, during demyelination induced by experimental autoimmune encephalomyelitis.

  1994cited by this paper
• Regulation of Oligodendrocyte Development and Central Nervous System Myelination by Insulin‐like Growth Factors a

  1993cited by this paper
• Multiple extracellular signals are required for long-term oligodendrocyte survival.

  1993cited by this paper
• Insulin-like growth factor I gene expression is induced in astrocytes during experimental demyelination.

  1992cited by this paper
• Insulin‐like growth factor I stimulates oligodendrocyte development and myelination in rat brain aggregate cultures

  1991cited by this paper
• Insulin‐like growth factor I promotes cell proliferation and oligodendroglial commitment in rat glial progenitor cells developing in vitro

  1988cited by this paper

• Insulin-like growth factor-1 receptor controls the function of CNS-resident macrophages and their contribution to neuroinflammation

  2023cites this paper
• IGF1R expression by adult oligodendrocytes is not required in the steady‐state but supports neuroinflammation

  2022cites this paper
• Reduced Fragmentation of IGFBP-2 and IGFBP-3 as a Potential Mechanism for Decreased Ratio of IGF-II to IGFBPs in Cerebrospinal Fluid in Response to Repeated Intrathecal Administration of Triamcinolone Acetonide in Patients With Multiple Sclerosis

  2021cites this paper
• Hormones in experimental autoimmune encephalomyelitis (EAE) animal models

  2021cites this paper
• mCSF-Induced Microglial Activation Prevents Myelin Loss and Promotes Its Repair in a Mouse Model of Multiple Sclerosis

  2018cites this paper
• Insulin-like growth factor-1 (IGF1) in systemic lupus erythematosus: relation to disease activity, organ damage and immunological findings

  2018cites this paper
• A genetically distinct microglial subset promotes myelination

  2017cites this paper
• Altered expression of IGF‐I system in neurons of the inflamed spinal cord during acute experimental autoimmune encephalomyelitis

  2017cites this paper
• IGF-1R signalling contributes to IL-6 production and T cell dependent inflammation in rheumatoid arthritis.

  2017cites this paper
• Extracellular cues influencing oligodendrocyte differentiation and (re)myelination.

  2016cites this paper
• Altered Autophagy-Associated Genes Expression in T Cells of Oral Lichen Planus Correlated with Clinical Features

  2016influential citation
• The role of growth factors as a therapeutic approach to demyelinating disease.

  2016cites this paper
• Targeting Insulin-Like Growth Factor 1 Leads to Amelioration of Inflammatory Demyelinating Disease

  2014cites this paper
• Insulin-like growth factor-1 stimulates regulatory T cells and suppresses autoimmune disease

  2014influential citation
• Promoting return of function in multiple sclerosis: An integrated approach.

  2013cites this paper
• Neuroprotection in Multiple Sclerosis: A Therapeutic Approach

  2013cites this paper
• Investigation of Sequential Growth Factor Delivery during Cuprizone Challenge in Mice Aimed to Enhance Oligodendrogliogenesis and Myelin Repair

  2013cites this paper
• Targeting growth factors to sites of inflammation:gene therapy for multiple sclerosis.

  2012cites this paper
• Progressive Axonal Injury in Chronic Plaques

  2012cites this paper
• Recombinant human IGF-1 for patients with schizophrenia.

  2011cites this paper
• Recombinant human IGF-1 for patients with schizophrenia

  2011cites this paper
• Cells of the oligodendroglial lineage, myelination, and remyelination.

  2011cites this paper
• Neuroprotection in multiple sclerosis: a therapeutic challenge for the next decade.

  2010cites this paper
• IGF-1 Can Either Protect Against or Increase LPS-Induced Damage in the Developing Rat Brain

  2010cites this paper
• Signals to promote myelin formation and repair

  2010cites this paper
• Extracellular matrix and oligodendrocyte regulators in different types of multiple sclerosis lesions: Implications for lesion development and regulation of remyelination

  2010cites this paper
• Effect of orally administered bovine colostrum on cytokine production in vivo and in vitro in immunosuppressed mice.

  2010cites this paper
• Adult‐onset deficiency in growth hormone and insulin‐like growth factor‐I alters oligodendrocyte turnover in the corpus callosum

  2009influential citation
• Insulin-like Growth Factor System Regulates Oligodendroglial Cell Behavior: Therapeutic Potential in CNS

  2008cites this paper
• Astrocytes—Friends or foes in multiple sclerosis?

  2007cites this paper
• Cellular approaches for stimulating CNS remyelination.

  2007cites this paper
• Differential effects of Th1, monocyte/macrophage and Th2 cytokine mixtures on early gene expression for glial and neural-related molecules in central nervous system mixed glial cell cultures: neurotrophins, growth factors and structural proteins

  2007influential citation